Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
bupi yishen granules + shenling baishu capsules
- Development stage
- Unknown
- Lead developer
- Consun Pharmaceutical
- Administration
- Oral
01
Overview
Bupi Yishen Granules + Shenling Baishu Capsules is a combination therapy consisting of two Traditional Chinese Medicine (TCM) formulations primarily used in China for the management of chronic kidney disease (CKD) and related renal conditions. Bupi Yishen Granules are designed to tonify the spleen and kidney, reduce urinary protein excretion, and delay the progression of renal insufficiency. Shenling Baishu Capsules are a classic TCM formula used to strengthen the spleen, transform dampness, and harmonize the stomach, addressing systemic symptoms of deficiency and fluid imbalance. In clinical practice, this combination is typically prescribed for patients exhibiting the 'spleen and kidney deficiency' pattern, aiming to provide synergistic effects in reducing proteinuria, improving renal function markers such as serum creatinine, and enhancing overall patient quality of life.
- Other names
- Bupi Yishen KeliShenling Baishu JiaonangBupi Yishen Granules and Shenling Baishu Capsules
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)TGFB1 (Transforming growth factor Beta-1 proprotein)
Beyond the preview
Go deeper on bupi yishen granules + shenling baishu capsules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on bupi yishen granules + shenling baishu capsules.